REFERENCES
- Schiffmann R, Fitzgibbon EJ, Harris C, et al. Randomized, controlled trial of miglustat in Gaucher’s disease type 3. Ann Neurol Nov 2008;64(5):514–522.
- Cogan DG, Chu FC, Gittinger J, Tychsen L. Fundal abnormalities of Gaucher’s disease. Arch Ophthalmol Dec 1980;98(12):2202–2203.
- Seidova SF, Kotliar K, Foerger F, Klopfer M, Lanzl I. Functional retinal changes in Gaucher disease. Doc Ophthalmol Apr 2009;118(2):151–154.
- Shrier EM, Barr CC, Grabowski GA. Vitreous opacities and retinal vascular abnormalities in Gaucher disease. Arch Ophthalmol Sep 2004;122(9):1395–1398.
- Wang TJ, Chen MS, Shih YF, Hwu WL, Lai MY. Fundus abnormalities in a patient with type I Gaucher’s disease with 12-year follow-up. Am J Ophthalmol Feb 2005;139(2):359–362.
- Stowens DW, Chu FC, Cogan DG, Barranger JA. Oculomotor deficits in Gaucher disease. Prog Clin Biolog Res 1982;95:143–147.